Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
Want to see SMMT full AI Analyst Report?
SMMT Analyst Ratings
Moderate Buy
9 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SMMT Stock 12 Month Forecast
Average Price Target
$29.56
▲(17.53% Upside)
| Highest Price Target$45.00 | Average Price Target$29.56 | Lowest Price Target$7.70 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
―
Hold
―
Downgraded
05/22/26
Stifel Nicolaus
$45
Buy
78.93%
Upside
Reiterated
05/22/26
Jefferies
$17
Hold
-32.41%
Downside
Reiterated
05/21/26
TD Cowen
―
Buy
―
Reiterated
05/06/26
Barclays
$18
Hold
-28.43%
Downside
Assigned
05/01/26
Piper Sandler
$17→$16
Hold
-36.38%
Downside
Reiterated
05/01/26
Evercore ISI
$34
Buy
35.19%
Upside
Reiterated
05/01/26
Goldman Sachs
$41
Buy
63.02%
Upside
Reiterated
05/01/26
Clear Street
$32→$31
Buy
23.26%
Upside
Reiterated
05/01/26
Citi
$40
Buy
59.05%
Upside
Reiterated
04/30/26
Guggenheim
$40
Buy
59.05%
Upside
Assigned
04/22/26
Wells Fargo
$30
Buy
19.28%
Upside
Reiterated
04/15/26
Truist Financial
$35
Buy
39.17%
Upside
Reiterated
02/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
―
Hold
―
Downgraded
05/22/26
Stifel Nicolaus
$45
Buy
78.93%
Upside
Reiterated
05/22/26
Jefferies
$17
Hold
-32.41%
Downside
Reiterated
05/21/26
TD Cowen
―
Buy
―
Reiterated
05/06/26
Barclays
$18
Hold
-28.43%
Downside
Assigned
05/01/26
Piper Sandler
$17→$16
Hold
-36.38%
Downside
Reiterated
05/01/26
Evercore ISI
$34
Buy
35.19%
Upside
Reiterated
05/01/26
Goldman Sachs
$41
Buy
63.02%
Upside
Reiterated
05/01/26
Clear Street
$32→$31
Buy
23.26%
Upside
Reiterated
05/01/26
Citi
$40
Buy
59.05%
Upside
Reiterated
04/30/26
Guggenheim
$40
Buy
59.05%
Upside
Assigned
04/22/26
Wells Fargo
$30
Buy
19.28%
Upside
Reiterated
04/15/26
Truist Financial
$35
Buy
39.17%
Upside
Reiterated
02/24/26
Best Analysts Covering Summit Therapeutics
3 Months
Success Rate
8/14 ratings generated profit
Average Return
+12.93%
Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +12.93% per trade.
1 Year
Success Rate
6/9 ratings generated profit
Average Return
+175.64%
Copying Bradley Canino's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +175.64% per trade.
2 Years
Success Rate
5/9 ratings generated profit
Average Return
+116.64%
Copying Bradley Canino's trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +116.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SMMT Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
5
10
11
15
13
Buy
4
2
2
3
5
Hold
3
4
5
4
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
1
total
12
16
18
22
26
Each month's total comprises the sum of three months' worth of ratings.
SMMT Financial Forecast
SMMT Stock Forecast FAQ
What is SMMT’s average 12-month price target, according to analysts?
Based on analyst ratings, Summit Therapeutics PLC’s 12-month average price target is 29.56.
What is SMMT’s upside potential, based on the analysts’ average price target?
Summit Therapeutics PLC has 17.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SMMT a Buy, Sell or Hold?
Summit Therapeutics PLC has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 1 sell ratings.
What is Summit Therapeutics PLC’s price target?
The average price target for Summit Therapeutics PLC is 29.56. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $7.70. The average price target represents 17.53% Increase from the current price of $25.15.
The highest analyst price target is $45.00 ,the lowest forecast is $7.70. The average price target represents 17.53% Increase from the current price of $25.15.
What do analysts say about Summit Therapeutics PLC?
Summit Therapeutics PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of SMMT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.